Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-16 09:01 am Purchase |
2024-09-30 | 13G | Tonix Pharmaceuticals Holding Corp. TNXP |
Empery Asset Management, LP | 17,399 1.340% |
17,399 (New Position) |
Filing History |
| 2024-10-16 09:00 am Unchanged |
2024-09-30 | 13G | Nuvve Holding Corp. NVVE |
Empery Asset Management, LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-10-09 09:02 am Purchase |
2024-09-30 | 13G | Volcon, Inc. VLCN |
Empery Asset Management, LP | 6,520 0.980% |
6,520 (New Position) |
Filing History |
| 2024-10-09 09:01 am Unchanged |
2024-09-30 | 13G | Elevation Oncology, Inc. ELEV |
Empery Asset Management, LP | 4,000,000 4.990% |
0 (Unchanged) |
Filing History |
| 2024-10-09 09:01 am Purchase |
2024-09-30 | 13G | Sharps Technology, Inc. STSS |
Empery Asset Management, LP | 539 4.990% |
539 (New Position) |
Filing History |
| 2024-10-09 09:00 am Purchase |
2024-09-30 | 13G | SOBR Safe, Inc. SOBR |
Empery Asset Management, LP | 570,928 1.620% |
570,928 (New Position) |
Filing History |
| 2024-01-23 12:51 pm Unchanged |
2023-12-31 | 13G | Cyngn Inc. CYN |
Empery Asset Management, LP | 373 4.990% |
0 (Unchanged) |
Filing History |
| 2024-01-11 4:53 pm Purchase |
2023-12-31 | 13G | Tonix Pharmaceuticals Holding Corp. TNXP |
Empery Asset Management, LP | 17,399 9.990% |
17,399 (New Position) |
Filing History |
| 2024-01-11 3:55 pm Purchase |
2023-12-31 | 13G | Volcon, Inc. VLCN |
Empery Asset Management, LP | 586 9.990% |
586 (New Position) |
Filing History |
| 2024-01-10 09:00 am Purchase |
2023-12-31 | 13G | Cyngn Inc. CYN |
Empery Asset Management, LP | 373 9.990% |
373 (New Position) |
Filing History |
| 2024-01-09 09:07 am Purchase |
2023-12-31 | 13G | Elevation Oncology, Inc. ELEV |
Empery Asset Management, LP | 4,000,000 6.700% |
4,000,000 (New Position) |
Filing History |
| 2024-01-09 09:06 am Purchase |
2023-12-31 | 13G | Cyngn Inc. CYN |
Empery Asset Management, LP | 354 9.990% |
354 (New Position) |
Filing History |
| 2024-01-09 09:05 am Purchase |
2023-12-31 | 13G | SOBR Safe, Inc. SOBR |
Empery Asset Management, LP | 10,924 6.090% |
10,924 (New Position) |
Filing History |
| 2024-01-09 09:03 am Purchase |
2023-12-31 | 13G | Nuvve Holding Corp. NVVE |
Empery Asset Management, LP | 11,260 9.990% |
11,260 (New Position) |
Filing History |
| 2024-01-08 10:26 am Sale |
2023-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Empery Asset Management, LP | 151,654 2.650% |
-54,969 (-26.60%) |
Filing History |
| 2024-01-08 10:25 am Unchanged |
2023-12-31 | 13G | Kiromic BioPharma, Inc. KRBP |
Empery Asset Management, LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-01-08 10:23 am Purchase |
2023-12-31 | 13G | RedHill Biopharma Ltd. RDHL |
Empery Asset Management, LP | 414,607 3.190% |
414,607 (New Position) |
Filing History |
| 2024-01-08 10:22 am Purchase |
2023-12-31 | 13G | Permex Petroleum Corporation OILCF |
Empery Asset Management, LP | 52,083 4.990% |
52,083 (New Position) |
Filing History |
| 2023-01-13 08:04 am Purchase |
2022-12-31 | 13G | RedHill Biopharma Ltd. RDHL |
Empery Asset Management, LP | 6,200 6.120% |
6,200 (New Position) |
Filing History |
| 2023-01-13 08:02 am Purchase |
2022-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Empery Asset Management, LP | 206,623 5.120% |
206,623 (New Position) |
Filing History |